Loading clinical trials...
Loading clinical trials...
Sexual Health and Rehabilitation After Ovarian Suppression Treatment (SHARE-OS): An Educational Intervention for Young Breast Cancer Survivors
This research study is evaluating an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of breast cancer recurrence.
The purpose of this research is to study the effectiveness of an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of cancer recurrence. The aim is to develop an effective intervention to help women manage these changes and restore sexual health and functioning. \- This study consists of attending a group educational session followed by a one-on-one telephone coaching session. * The group educational session will last about 4 hours, and will include information on resources, self-help strategies, and relaxation techniques. * The telephone coaching session will take place four weeks after the group session, and will last about 15 minutes
Age
18 - 50 years
Sex
FEMALE
Healthy Volunteers
No
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
December 1, 2018
Primary Completion Date
December 1, 2019
Completion Date
December 1, 2019
Last Updated
November 12, 2021
20
ACTUAL participants
Group Session
BEHAVIORAL
Telephone Booster
BEHAVIORAL
Lead Sponsor
Dana-Farber Cancer Institute
Collaborators
NCT07379918
NCT06478589
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06729684